PINS-N 0.15 OWL-N 0.19 AC-T 0.3 LVMUY-OTC 0 ACN-N 0.72 UNH-N -59.75 VALT-T -1.12
PanGeo Pharma (PIL.H-X)

PanGeo Pharma (PIL.H-X)

0 watching

0.00
0.00 (0.00%) 1d
0

Related posts

Nervous markets await Nvidia
DON'T BUY

PanGeo Pharma(PIL.H-X)

Sep 22, 2003
Trading has been stopped. Plagued by a number of problems. Waiting for the company to complete its audit.
Robert FloydRobert Floyd
Owned
Unlock Rating
$0.290

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H-X)

Jul 22, 2003
Doesn't look good.
David BurrowsDavid Burrows
No
Unlock Rating
$0.290

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H-X)

Jul 04, 2003
Auditors left and have to be replaced and trading has been stopped until their reports are in.
Robert FloydRobert Floyd
Owned
Unlock Rating
$0.290

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H-X)

Jul 02, 2003
In a very defined downtrend.
Bill CarriganBill Carrigan
No
Unlock Rating
$0.290

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H-X)

May 30, 2003
Very extended. Squeezing their credit lines and suppliers. Have to earn $0.10 a share to support the liquidity issue.
Lou SchizasLou Schizas
Unknown
Unlock Rating
$0.740

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H-X)

May 06, 2003
Have had some pretty big earnings misses and management issues. May be a take over target at some point. Wait for it to drop further.
Peter HodsonPeter Hodson
Unknown
Unlock Rating
$0.960

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H-X)

Apr 25, 2003
Made a good move in splitting the offices of the chairman and the CEO. They are trying to deal with their problems. Have to see an improvement before there is any interest.
Robert FloydRobert Floyd
Unknown
Unlock Rating
$0.760

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

PanGeo Pharma(PIL.H-X)

Apr 10, 2003
Has warned a few times. Making some strategic moves in beefing up their management. A reasonable bet.
Robert FloydRobert Floyd
Unknown
Unlock Rating
$0.770

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H-X)

Mar 31, 2003
Likes this sector, but they just gave a lower guidance.
John Sinkins, CFAJohn Sinkins, CFA
Unknown
Unlock Rating
$0.690

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

PanGeo Pharma(PIL.H-X)

Mar 27, 2003
Earnings warnings were forcast. Seems to be corrected now. Cheap.
Robert FloydRobert Floyd
Unknown
Unlock Rating
$0.730

Stock price when the opinion was issued

biotechnology pharmaceutical
HOLD

PanGeo Pharma(PIL.H-X)

Mar 03, 2003
Making some management changes which will take time.
Robert FloydRobert Floyd
Unknown
Unlock Rating
$0.830

Stock price when the opinion was issued

biotechnology pharmaceutical
PAST TOP PICK

PanGeo Pharma(PIL.H-X)

Feb 07, 2003
(Was a top pick on Dec 18.Down 55%.) Stock was knocked down, but problems are being looked after.
Robert FloydRobert Floyd
Unknown
Unlock Rating
$0.920

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H-X)

Feb 04, 2003
Way off on their earnings guidance. Will take a while to recover.
Peter HodsonPeter Hodson
Unknown
Unlock Rating
$1.010

Stock price when the opinion was issued

biotechnology pharmaceutical
WEAK BUY

PanGeo Pharma(PIL.H-X)

Feb 03, 2003
Could go up. Has been oversold. Treat as a trade.
Michael SmedleyMichael Smedley
Unknown
Unlock Rating
$1.110

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

PanGeo Pharma(PIL.H-X)

Jan 31, 2003
Has missed for the 3rd time. Prefers others.
Andrew McCreathAndrew McCreath
Unknown
Unlock Rating
$0.930

Stock price when the opinion was issued

biotechnology pharmaceutical
Showing 1 to 15 of 33 entries
Next PageNext Page

PanGeo Pharma(PIL.H-X) Rating

Ranking : 1 out of 5

Star iconStar empty iconStar empty iconStar empty iconStar empty icon

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for PanGeo Pharma is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

PanGeo Pharma(PIL.H-X) Frequently Asked Questions

What is PanGeo Pharma stock symbol?

PanGeo Pharma is a OTC stock, trading under the symbol PIL.H-X on the (). It is usually referred to as or PIL.H-X

Is PanGeo Pharma a buy or a sell?

In the last year, there was no coverage of PanGeo Pharma published on Stockchase.

Is PanGeo Pharma a good investment or a top pick?

PanGeo Pharma was recommended as a Top Pick by on . Read the latest stock experts ratings for PanGeo Pharma.

Why is PanGeo Pharma stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is PanGeo Pharma worth watching?

In the last year 0 stock analysts on Stockchase covered PanGeo Pharma. The stock is worth watching.

What is PanGeo Pharma stock price?

On , PanGeo Pharma (PIL.H-X) stock closed at a price of $.

Build our watch list

Sign in to track investments
you care about

Latest Buy Signals

NEO-T 0.14$11.16
EG-N 0.53$348.33
CJT-T 0.71$95.73
LNR-T 0.82$61.86
FIVE-Q 0.22$103.71

Today's Top Picks

PINS-N 0.15$32.99
OWL-N 0.19$19.83
AC-T 0.3$18.67
LVMUY-… 0$118.11
ACN-N 0.72$322.81

Popular Articles

Latest Sell Signals

ENB-T 0.47$62.76
DVN-N 0.4$33.95
HPE-N 0.13$17.87
CRYPTO… 64.50319430807$2560.11179466055
GOOG-Q 1.51$161.09

Most Recent Experts

Larry Berman CFA, CMT, CTA

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Teal Linde

Teal Linde

Linde Equity Report

Stockchase Insights

Stockchase Insights

5i Research

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Michael Hakes - CFA, MBA

Michael Hakes - CFA, MBA

Murray Wealth Group

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: hello@stockchase.com.

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© Stockchase Inc. by Wealthica